Sujata Tyagi Dayal - 21 Jul 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: Director
Signature: /s/ Brian Millard, Attorney-in-fact
Issuer symbol: EBS
Transactions as of: 21 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Jul 2022, 16:16:46 UTC
Previous filing: 22 Jul 2022
Next filing: 30 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+11,852		$0.000000	11,852	21 Jul 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

Content

Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.